| Institution: | 1. Lilly Suzhou Pharmaceutical Company, Ltd., Shanghai, China;2. Eli Lilly and Company, Sydney, Australia;3. Eli Lilly and Company, Indianapolis, IN, USA;4. Real World Insights, IQVIA, Shanghai, China;1. Department of Adult Critical Care Medicine, Tainan Sin-Lau Hospital, Tainan, Taiwan;2. Graduate Institute of Medical Sciences, College of Health Sciences, Chang Jung Christian University, Tainan, Taiwan;3. Department of Emergency Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan;4. Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan;5. Department of Medicine, Chi-Mei Medical Center, Tainan, Taiwan;6. Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan, Taiwan;7. Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan;1. Department of Pediatrics, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, CA, USA;2. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, CA, USA;3. Department of Medicine, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, CA, USA;4. Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, CA, USA |
